ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
127.850,70
-0,34%
S&P 500
5.296,74
-0,01%
US Dollar vs BRL
5,1138
-0,32%
Bitcoin
67.195,43
3,00%
Brent Oil
83,395
0,23%
Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Adma Biologics Inc (ADMA)

  7. Adma Biologics Inc (ADMA) Notícias

ADMA

Adma Biologics (ADMA)

Adma Biologics Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:ADMA
DataHoraFonteTítuloCódigoCompanhia
17/05/202410:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADMAAdma Biologics Inc
09/05/202418:01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ADMAAdma Biologics Inc
09/05/202417:05GlobeNewswire Inc.ADMA Biologics Announces First Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:ADMAAdma Biologics Inc
09/05/202408:47IH Market NewsU.S. Index Futures Dip, Bank of England Holds Interest Rates at 5.25%NASDAQ:ADMAAdma Biologics Inc
02/05/202408:00GlobeNewswire Inc.ADMA Biologics to Report First Quarter 2024 Financial Results on May 9, 2024NASDAQ:ADMAAdma Biologics Inc
11/03/202413:19Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ADMAAdma Biologics Inc
11/03/202408:00GlobeNewswire Inc.ADMA Biologics Announces FDA Approvals of Extended Room Temperature Storage Conditions for ASCENIV™ & BIVIGAM®NASDAQ:ADMAAdma Biologics Inc
08/03/202423:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ADMAAdma Biologics Inc
05/03/202409:00GlobeNewswire Inc.ADMA Biologics to Participate in the Raymond James Institutional Investor ConferenceNASDAQ:ADMAAdma Biologics Inc
28/02/202418:10GlobeNewswire Inc.ADMA Biologics Announces CFO TransitionNASDAQ:ADMAAdma Biologics Inc
28/02/202418:05GlobeNewswire Inc.ADMA Biologics Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdateNASDAQ:ADMAAdma Biologics Inc
21/02/202418:05GlobeNewswire Inc.ADMA Biologics to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024NASDAQ:ADMAAdma Biologics Inc
21/02/202409:00GlobeNewswire Inc.ADMA Biologics Successfully Implements Innovative AI Program, Named ADMAlyticsNASDAQ:ADMAAdma Biologics Inc
14/02/202413:50Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:ADMAAdma Biologics Inc
08/01/202409:00GlobeNewswire Inc.ADMA Biologics Announces Preliminary Fourth Quarter 2023 Revenue and Provides Business UpdateNASDAQ:ADMAAdma Biologics Inc
18/12/202318:05GlobeNewswire Inc.ADMA Biologics Announces $135 Million Non-Dilutive Refinancing of Credit Facilities with Ares ManagementNASDAQ:ADMAAdma Biologics Inc
12/12/202309:00GlobeNewswire Inc.ADMA Biologics Announces FDA Approval for BIVIGAM® in the Pediatric Patient Setting for Those 2 Years of Age and OlderNASDAQ:ADMAAdma Biologics Inc
16/11/202309:00GlobeNewswire Inc.ADMA BioCenters Receives FDA Approval for its Tenth Plasma Collection Center, Located in Laurel, MDNASDAQ:ADMAAdma Biologics Inc
08/11/202318:05GlobeNewswire Inc.ADMA Biologics Announces Third Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:ADMAAdma Biologics Inc
01/11/202308:00GlobeNewswire Inc.ADMA Biologics to Report Third Quarter 2023 Financial Results on November 8, 2023NASDAQ:ADMAAdma Biologics Inc
02/10/202317:46Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ADMAAdma Biologics Inc
22/08/202318:09Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ADMAAdma Biologics Inc
18/08/202313:58Edgar (US Regulatory)Form 144/A - Report of proposed sale of securities: [Amend]NASDAQ:ADMAAdma Biologics Inc
09/08/202317:05GlobeNewswire Inc.ADMA Biologics Announces Second Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:ADMAAdma Biologics Inc
02/08/202308:00GlobeNewswire Inc.ADMA Biologics to Report Second Quarter 2023 Financial Results on August 9, 2023NASDAQ:ADMAAdma Biologics Inc
06/06/202317:31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ADMAAdma Biologics Inc
22/05/202308:32Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:ADMAAdma Biologics Inc
10/05/202318:02Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ADMAAdma Biologics Inc
10/05/202317:05GlobeNewswire Inc.ADMA Biologics Announces First Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:ADMAAdma Biologics Inc
03/05/202308:00GlobeNewswire Inc.ADMA Biologics to Report First Quarter 2023 Financial Results on May 10, 2023NASDAQ:ADMAAdma Biologics Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:ADMA

Seu Histórico Recente

BOV
GFSA3
GAFISA ON
BOV
IBOV
Índice Bovespa
BOV
HBOR3
HELBOR ON
BOV
PRIO3
PETRORIO ON
BOV
TPIS3
TRIUNFO PART ON
BOV
ENAT3
ENAUTA ON
BOV
OPCT3
Oceanpact Servicos Marit... ON
BOV
OIBR3
OI ON
BOV
IRBR3
IRB BRASIL ON
BOV
RRRP3
3R Petroleum Oleo E Gas ... ON
BOV
COGN3
COGNA ON
BOV
HAGA3
HAGA ON
BOV
LIGT3
LIGHT ON
BOV
NGRD3
Neogrid Participacoes ON
BOV
HOOT4
HOTEIS OTHON PN
BOV
RPMG3
PET MANGUINH ON
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados